SELLAS to Present at UBS Virtual Global Healthcare Conference

NEXT STORY
Press release Oncology Venture issues 1,952,475 new shares in connection with debt conversions
PREV STORY
ADMA Biologics Provides Corporate Update on Supply Chain Robustness and Recent Accomplishments
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Amarin Announces First Middle East Approval for Vascepa®

BEDMINSTER, N.J. and DUBLIN, Ireland, March 21, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), ...

author_avatar
NASDAQ Market News

Conatus Pharmaceuticals Announces Publications Expanding on Previously Reported Results from Completed Phase 2 NAFLD-NASH, Portal Hypertension and Liver Cirrhosis Clinical Trials

SAN DIEGO, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced ...

author_avatar
NASDAQ Market News

Myriad Announces Closing of Counsyl Acquisition

Transformational Acquisition Enhances Myriad’s Leadership Position in Women’s HealthSALT LAKE CITY, July 31, 2018 ...

author_avatar
NASDAQ Market News